Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ansell's gross profit for the
six
months ended in Dec. 2025 was A$634 Mil. Ansell's gross profit for the trailing twelve months (TTM) ended in Dec. 2025 was A$1,289 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Ansell's gross profit for the
six
months ended in Dec. 2025 was A$634 Mil. Ansell's Revenue for the
six
months ended in Dec. 2025 was A$1,545 Mil. Therefore, Ansell's Gross Margin % for the quarter that ended in Dec. 2025 was 41.04%.
Ansell had a gross margin of 41.04% for the quarter that ended in Dec. 2025 => Durable competitive advantage
During the past 13 years, the highestGross Margin % of Ansell was 42.17%. The lowest was 34.11%. And the median was 39.16%.
Ansell (ASX:ANN) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Ansell had a gross margin of 41.04% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Ansell Gross Profit Related Terms
Ansell Gross Profit Historical Data
* Premium members only.
The historical data trend for Ansell's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ANN vs ISRG, BDX, MDLN: Gross Profit Comparison
For the Medical Instruments & Supplies subindustry, Ansell's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ansell Gross Profit vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ansell's Gross Profit distribution charts can be found below:
* The bar in red indicates where Ansell's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1,289 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
Ansell's Gross Margin % for the quarter that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Ansell (ASX:ANN) has a Gross Profit of A$1,289 Mil as of Dec. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on Ansell and its competitors.
Is Ansell's Gross Profit too high?
Ansell's current Gross Profit is A$1,289 Mil. Overall, Ansell has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ansell's Gross Profit compare to ISRG and BDX?
Ansell's Gross Profit of A$1,289 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Ansell and its competitors. Ansell's current Gross Profit is A$1,289 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ansell stock overvalued right now?
Based on GuruFocus' analysis, Ansell (ASX:ANN) is currently considered Fairly Valued. The stock's GF Value™ is A$29.42, compared to a current price of A$31.67 — trading 7.6% above its estimated fair value. The current Gross Profit is A$1,289 Mil. Ansell's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Ansell (ASX:ANN), the current Gross Profit is A$1,289 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ansell (ASX:ANN) Overvalued in 2026?
Based on GuruFocus' analysis, Ansell stock appears to be overvalued.
The current stock price of A$31.67 is trading 7.6% above its estimated GF Value™ of A$29.42.
GuruFocus considers Ansell to be Fairly Valued.
Key valuation signals for ASX:ANN:
Gross Profit: A$1,289 Mil
GF Value™: A$29.42 vs. price of A$31.67 (7.6% above fair value)
No single metric tells the full story. See the ASX:ANN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales.
76GF Score
Get the complete analysis for ASX:ANN
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ANN has been successfully added to your 
